First patient enrolled in head-to-head study of MS treatment
First patient enrolled in head-to-head study of MS treatment
Study to evaluate possible benefits of switching to Tysabri from Copaxone or Rebif commences. - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1768
MS-UK - http://www.ms-uk.org/